WallStreetZenWallStreetZen

NASDAQ: ICCT
Icoreconnect Inc Stock

$1.10+0.02 (+1.85%)
Updated Apr 26, 2024
ICCT Price
$1.10
Fair Value Price
N/A
Market Cap
$11.12M
52 Week Low
$0.91
52 Week High
$20.70
P/E
-0.5x
P/B
2.5x
P/S
1.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.15M
Earnings
-$15.55M
Gross Margin
75.1%
Operating Margin
-177.17%
Profit Margin
-195.3%
Debt to Equity
2.53
Operating Cash Flow
-$9M
Beta
4.84
Next Earnings
Jun 14, 2024
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ICCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ICCT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ICCT is good value based on its book value relative to its share price (2.5x), compared to the US Health Information Services industry average (3.38x)
P/B vs Industry Valuation
ICCT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ICCT due diligence checks available for Premium users.

Be the first to know about important ICCT news, forecast changes, insider trades & much more!

ICCT News

Valuation

ICCT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.5x
Industry
72.49x
Market
41.14x

ICCT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.5x
Industry
3.38x
ICCT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ICCT's financial health

Profit margin

Revenue
$2.5M
Net Income
-$7.5M
Profit Margin
-310.7%
ICCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ICCT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$15.7M
Liabilities
$11.2M
Debt to equity
2.53
ICCT's short-term liabilities ($8.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ICCT's short-term assets ($3.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ICCT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ICCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.1M
Investing
-$225.1k
Financing
$8.1M
ICCT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ICCT vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
ICCT$11.12M+1.30%-0.50x2.50x
CMAX$11.86M+8.90%-0.02x0.19x
ONMD$13.48M+0.89%-0.58x-1.05x
OTRK$13.97M-12.01%-0.09x0.98x
ETAO$15.86M+1.52%-0.02x-1.02x

Icoreconnect Stock FAQ

What is Icoreconnect's quote symbol?

(NASDAQ: ICCT) Icoreconnect trades on the NASDAQ under the ticker symbol ICCT. Icoreconnect stock quotes can also be displayed as NASDAQ: ICCT.

If you're new to stock investing, here's how to buy Icoreconnect stock.

What is the 52 week high and low for Icoreconnect (NASDAQ: ICCT)?

(NASDAQ: ICCT) Icoreconnect's 52-week high was $20.70, and its 52-week low was $0.91. It is currently -94.71% from its 52-week high and 20.2% from its 52-week low.

How much is Icoreconnect's stock price per share?

(NASDAQ: ICCT) Icoreconnect stock price per share is $1.10 today (as of Apr 26, 2024).

What is Icoreconnect's Market Cap?

(NASDAQ: ICCT) Icoreconnect's market cap is $11.12M, as of Apr 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Icoreconnect's market cap is calculated by multiplying ICCT's current stock price of $1.10 by ICCT's total outstanding shares of 10,150,753.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.